Eduard Vieta, MD

Bipolar and Depressive Disorders Unit, Hospital Clínic de Barcelona, Barcelona, Spain; Institute of Neurosciences (UBNeuro); Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Biomedical Research Networking Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III (ISCIII); Biomedical Research Networking Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III (ISCIII)

Article

Developing an Individualized Treatment Plan for Patients With Schizoaffective Disorder: From Pharmacotherapy to Psychoeducation

December 23, 2010

Eduard Vieta

Educational Activity

Individualizing Treatment for Patients With Schizoaffective Disorder

October 15, 2010

Eduard Vieta

Educational Activity

Role of Antidepressants in Bipolar Depression

September 15, 2010

Eduard Vieta

Original Research

Poor Long-Term Prognosis in Mixed Bipolar Patients: 10-Year Outcomes in the Vitoria Prospective Naturalistic Study in Spain

September 7, 2010

Eduard Vieta, Ana Gonzalez-Pinto, Rafael Tabarés-Seisdedos, et al

Original Research

Detection of Subclinical Depression in Bipolar Disorder: A Cross-Sectional, 4-Month Prospective Follow-Up Study at Community Mental Health Services (SIN-DEPRES)

August 10, 2010

Eduard Vieta, Alfonso Rodriguez, Miguel A. Jiménez-Arriero, et al

Original Research

McLean-Harvard International First-Episode Project: Two-Year Stability of ICD-10 Diagnoses in 500 First-Episode Psychotic Disorder Patients

July 13, 2010

Mauricio Tohen, Ross J. Baldessarini, Eduard Vieta, et al

Original Research

Why Do Clinicians Maintain Antidepressants in Some Patients With Acute Mania? Hints From the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a Large Naturalistic Study

March 23, 2010

Eduard Vieta, Catherine Reed, Jose Sanchez-Moreno, et al

Original Research

Lithium Treatment Effects on the Neuropsychological Functioning of Patients With Bipolar I Disorder

March 23, 2010

Eduard Vieta, Carla Torrent, Carlos López-Jaramillo, et al

Educational Activity

Long-Term Treatment of Bipolar Depression and Other Issues

March 15, 2010

Eduard Vieta

Original Research

Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder: A 6-Month, Randomized, Placebo-Controlled, Double-Blind Trial

January 26, 2010

Eduard Vieta, Charles L. Bowden, Mark Versavel, et al

Original Research

Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression: A Multicenter, Double-Blind, Placebo-Controlled Trial

December 30, 2009

Eduard Vieta, Willem A. Nolen, Paul G. H. Mulder, et al

Original Research

McLean-Harvard International First-Episode Project: Two-Year Stability of DSM-IV Diagnoses in 500 First-Episode Psychotic Disorder Patients

December 30, 2009

Carlos A. Zarate, Jr., Mauricio Tohen, Ross J. Baldessarini, et al

« 1 2 3 4 5 … 7 »

Eduard Vieta, MD

Developing an Individualized Treatment Plan for Patients With Schizoaffective Disorder: From Pharmacotherapy to Psychoeducation

Individualizing Treatment for Patients With Schizoaffective Disorder

Role of Antidepressants in Bipolar Depression

Poor Long-Term Prognosis in Mixed Bipolar Patients: 10-Year Outcomes in the Vitoria Prospective Naturalistic Study in Spain

Detection of Subclinical Depression in Bipolar Disorder: A Cross-Sectional, 4-Month Prospective Follow-Up Study at Community Mental Health Services (SIN-DEPRES)

McLean-Harvard International First-Episode Project: Two-Year Stability of ICD-10 Diagnoses in 500 First-Episode Psychotic Disorder Patients

Why Do Clinicians Maintain Antidepressants in Some Patients With Acute Mania? Hints From the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a Large Naturalistic Study

Lithium Treatment Effects on the Neuropsychological Functioning of Patients With Bipolar I Disorder

Long-Term Treatment of Bipolar Depression and Other Issues

Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder: A 6-Month, Randomized, Placebo-Controlled, Double-Blind Trial

Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression: A Multicenter, Double-Blind, Placebo-Controlled Trial

McLean-Harvard International First-Episode Project: Two-Year Stability of DSM-IV Diagnoses in 500 First-Episode Psychotic Disorder Patients

ELSEWHERE:

FOLLOW US:

Eduard Vieta, MD

Developing an Individualized Treatment Plan for Patients With Schizoaffective Disorder: From Pharmacotherapy to Psychoeducation

Individualizing Treatment for Patients With Schizoaffective Disorder

Role of Antidepressants in Bipolar Depression

Poor Long-Term Prognosis in Mixed Bipolar Patients: 10-Year Outcomes in the Vitoria Prospective Naturalistic Study in Spain

Detection of Subclinical Depression in Bipolar Disorder: A Cross-Sectional, 4-Month Prospective Follow-Up Study at Community Mental Health Services (SIN-DEPRES)

McLean-Harvard International First-Episode Project: Two-Year Stability of ICD-10 Diagnoses in 500 First-Episode Psychotic Disorder Patients

Why Do Clinicians Maintain Antidepressants in Some Patients With Acute Mania? Hints From the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a Large Naturalistic Study

Lithium Treatment Effects on the Neuropsychological Functioning of Patients With Bipolar I Disorder

Long-Term Treatment of Bipolar Depression and Other Issues

Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder: A 6-Month, Randomized, Placebo-Controlled, Double-Blind Trial

Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression: A Multicenter, Double-Blind, Placebo-Controlled Trial

McLean-Harvard International First-Episode Project: Two-Year Stability of DSM-IV Diagnoses in 500 First-Episode Psychotic Disorder Patients

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles